UB Paderborn / Katalog / Suche / in CDI

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Leukemia, 2014-07, Vol.28 (7), p.1529-1536

2014

Link zum Volltext

Verfügbarkeit prüfen

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2015-07, Vol.373 (3), p.209-219

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-12-07: Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with progression in the CNS after trastuzumab (TRIO-US B-09)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-07

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD5-11: Not presented

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD5-11-PD5-11

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials networks, accrual strategies, and enrollment of historically underrepresented populations in medical oncology trials

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16549-e16549

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract S1-02: Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles of docetaxel and carboplatin with trastuzumab and/or lapatinib in patients with HER2+ breast cancer (TRIO-US B07)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.S1-S1-02

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials networks and enrollment of historically underrepresented populations in medical oncology trials

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20598-e20598

2009

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study of PD 0332991, cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole for first-line treatment of patients with postmenopausal, estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS100-TPS100

2011

Link zum Volltext

Verfügbarkeit prüfen

Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.6094-6094

2009

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of neoadjuvant docetaxel/carboplatin with or without trastuzumab in locally advanced breast cancer: Response and cardiotoxicity

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10515-10515

2006

Link zum Volltext

Verfügbarkeit prüfen

Stereospecific production of the herbicide phosphinothricin (glufosinate) by transamination: cloning, characterization, and overexpression of the gene encoding a phosphinothricin-specific transaminase from Escherichia coli

Applied and Environmental Microbiology, 1990-01, Vol.56 (1), p.7-12

1990

Link zum Volltext

Verfügbarkeit prüfen

P1-17-05: Preliminary Results of a Randomized Phase 2 Study of PD 0332991, a Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor, in Combination with Letrozole for First-Line Treatment of Patients (pts) with Post-Menopausal, ER+, HER2−Negative (HER2–) Advanced Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-17-05

2011

Link zum Volltext

Verfügbarkeit prüfen

Stereospecific production of the herbicide phosphinothricin (glufosinate) by transamination: cloning, characterization, and overexpression of the gene encoding a phsophinothricin-specific transaminase from Escherichia coli

Applied and environmental microbiology, 1990, Vol.56 (1), p.7-12

1990

Link zum Volltext

Verfügbarkeit prüfen

Gestosis index and perinatal mortality

Zentralblatt für Gynäkologie, 1975, Vol.97 (19), p.1201

1975

Link zum Volltext

Verfügbarkeit prüfen

The significance of guided patient education on the value of metabolic control in a district center for diabetes mellitus

Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete, 1981-07, Vol.36 (14), p.491

1981

Link zum Volltext

Verfügbarkeit prüfen

Lower Blood Glucose, Hyperglucagonemia, and Pancreatic α Cell Hyperplasia in Glucagon Receptor Knockout Mice

Proceedings of the National Academy of Sciences - PNAS, 2003-02, Vol.100 (3), p.1438-1443

2003

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2021-03, Vol.384 (9), p.829-841

2021

Link zum Volltext

Verfügbarkeit prüfen

Genome of the Western Clawed Frog Xenopus tropicalis

Science (American Association for the Advancement of Science), 2010-04, Vol.328 (5978), p.633-636

2010

Link zum Volltext

Verfügbarkeit prüfen

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature communications, 2020-11, Vol.11 (1), p.5824-15, Article 5824

2020

Link zum Volltext

Verfügbarkeit prüfen

The atypical RNA-binding protein Taf15 regulates dorsoanterior neural development through diverse mechanisms in Xenopus tropicalis

Development (Cambridge), 2021-08, Vol.148 (15)

2021

Link zum Volltext

Verfügbarkeit prüfen

Uric Acid: A Less‐than‐Perfect Probe for Singlet Oxygen

Photochemistry and photobiology, 2019-01, Vol.95 (1), p.202-210

2019

Link zum Volltext

Verfügbarkeit prüfen

Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation

Developmental dynamics, 2002-11, Vol.225 (3), p.260-270

2002

Link zum Volltext

Verfügbarkeit prüfen

Danish Register of chronic obstructive pulmonary disease

Clinical epidemiology, 2016-01, Vol.8, p.673-678

2016

Link zum Volltext

Verfügbarkeit prüfen

Photophysics of a protein-bound derivative of malachite green that sensitizes the production of singlet oxygen

Photochemical & photobiological sciences, 2021-03, Vol.20 (3), p.435-449

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Abstract P1-12-07: Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with progression in the CNS after trastuzumab (TRIO-US B-09)

Abstract PD5-11: Not presented

Clinical trials networks, accrual strategies, and enrollment of historically underrepresented populations in medical oncology trials

Abstract S1-02: Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles of docetaxel and carboplatin with trastuzumab and/or lapatinib in patients with HER2+ breast cancer (TRIO-US B07)

Clinical trials networks and enrollment of historically underrepresented populations in medical oncology trials

A randomized phase II study of PD 0332991, cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole for first-line treatment of patients with postmenopausal, estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer

Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer

A phase II study of neoadjuvant docetaxel/carboplatin with or without trastuzumab in locally advanced breast cancer: Response and cardiotoxicity

Stereospecific production of the herbicide phosphinothricin (glufosinate) by transamination: cloning, characterization, and overexpression of the gene encoding a phosphinothricin-specific transaminase from Escherichia coli

P1-17-05: Preliminary Results of a Randomized Phase 2 Study of PD 0332991, a Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor, in Combination with Letrozole for First-Line Treatment of Patients (pts) with Post-Menopausal, ER+, HER2−Negative (HER2–) Advanced Breast Cancer

Stereospecific production of the herbicide phosphinothricin (glufosinate) by transamination: cloning, characterization, and overexpression of the gene encoding a phsophinothricin-specific transaminase from Escherichia coli

Gestosis index and perinatal mortality

The significance of guided patient education on the value of metabolic control in a district center for diabetes mellitus

Lower Blood Glucose, Hyperglucagonemia, and Pancreatic α Cell Hyperplasia in Glucagon Receptor Knockout Mice

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Genome of the Western Clawed Frog Xenopus tropicalis

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

The atypical RNA-binding protein Taf15 regulates dorsoanterior neural development through diverse mechanisms in Xenopus tropicalis

Uric Acid: A Less‐than‐Perfect Probe for Singlet Oxygen

Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation

Danish Register of chronic obstructive pulmonary disease

Photophysics of a protein-bound derivative of malachite green that sensitizes the production of singlet oxygen

Suchergebnisse filtern